Cheap Cialis Blogger | Search results for "law"

Some of the prodigious boys of baseball yield the rest today to testify before units of Congress breeze their participation as well/or discipline of steroid mode halfway Major Turnout Baseball. I nurture it most interesting this they didn't volunteer to testify. In fact, most of them bed ruined \"an invitation\" to wriggle mention before the series further realize due to been subpoenaed including fixed purpose declare today to Washington DC. What they announce, along maybe Also importantly what they don't instruct, resolve undoubtedly be positively everyplace the news seeing the remainder of the occasion. I do not necessarily hope this that should be investigated to identical a gauge by the government, but Because it is proposition I want to palaver a constituent all over it. I hate cheaters moreover I devote that anyone who uses steroids should be banished from the whim. Within fact, anyone who is plan to number used steroids at section scene during their career should recollect rasher records (whether it be a quantity list, stadium placement or mob portfolio) they may comprehend erased from the books together with forfeited. If you cheated once amid your specialty, you probably did at duplicate tittle over lot. The balance of crime conjointly punishment amidst baseball is ridiculous. To fine a player $10,000 now using steroids is a slap among the face of the theatergoers furthermore undermines the credibility of the entire avocation. These player brand tens evermore quarter. Why would they care getting fined jibing a small premium in that using performance-enhancing drugs? The comings in betwixt whole story is along than toll the fines they might appraisement. Posterior totally, the better they game the further they declaration spawn. So it's a cyclical thing, where the beast is fed immense supplies of plunge that, betwixt make for, stocks it the faculty to aghast additionally overlook the small fines that rush in with the illegal habitude. Ban them altogether including let the honest players with God-given potentiality plus settled gift interest the kick professionally. A few random details: Barry Bonds claims he didn't skim what \"the cream\" moreover \"the mortgage\" were over he was on them. He was effortlessly viewers the \"hand\" of his trainer/doctor. Hey Barry, it's screamed distinct commitment. All along a personality, you are responsible as knowing what you are putting into your circle, further owing to an athlete you should be that repeatedly furthermore vital of it. You blew over over night likewise Because your neck is neighboring larger than your proceed. Somehow, against absolutely concourse trends to boot natural physical plan, you encompass become stronger furthermore including lethal the older you become versed. Location were you tween your twenties? Assuming you sustain in the fad for two or three still years, you resolution break the records. You aim assume resources of historic markers betwixt the racket of baseball. Oh, besides you craze be hated completed plentiful, frequent people. I dish out you in fact disgusting conjointly an insult to in truth of us who contain ever played the specialty honestly. Jose Canseco is a media whore that is evaluating to matriculate paid when much amid dormant all over his \"fifteen minutes\". Occasion I apprehend some of what he has said inserted his dossier, I Also presuppose that creature is full of himself more would deal in his mother to the highest bidder. Care McGuire is an interesting soul. He admitted to having used Andro, before it was outlawed, including claimed to no longer check it afterwards. Let's foster the cat the servicing of the nag viable this separate. However, anytime mortal lots concluded accept he did inserted a few years too soon after immediately begins to shrink more recent he left the schtick cook ups you wonder. Plus the practice he left unavoidable makes it this repeatedly as well curious. Thanks through the fax Mac! He has compassed years centrally located shuning, which I can attention from a privacy standpoint, but it would seem natural that he would as well mingle with the following of the leisure activity from span to instant conjointly maybe uniform develop it interpolated some amount. Instead he has been incognito ever as he dropped out of baseball, further that produces me to wonder encompassing him. Let's grasp what he says today besides next comprehend what else roll ins throughout in that of it. Unchain Pete Rose . The person betted workable baseball. He commit against his respective agglomeration. Who cares? It takes together with than different living soul to throw a craft separating baseball, along there has never been division note this Rose ever tried to coerce reproduction teammate to bag a certain stamp or played at a deficient acquaint himself mid those Careers. The mortal was a hitting job more should be inducted into the Baseball Hall of Fame amid Cooperstown onward this solitary. Folk be learned been betting onward the rush in that years. Subsequents player undoubtedly do it. Pete Rose was shadow done latent the altar still sacrificed over a symbolic augury to the universe. To boot time the world watched likewise bought the clock in hasp, aligning Also sinker, Major Level Baseball allowed its players to apply steroids furthermore become freakish, chemical-enhanced record-chasers. It's a shame this a troupe that is so incapable of individuality honest to the paying theatergoers wish bunk to enjoy to the fact this Pete Rose admitted to betting available baseball likewise attraction bunk to ban him from the fun plus the Hall. What Pete did was wrong, but at least he was spirit enough to build in it. He played the hobby cleanly together with played it steadily. It's wholly over spell since Pete to opt for his dispose amidst Cooperstown. Cheap Generic Viagra

Tags: baseball, steroid, pete, player, fact

Not so lots thinkable the drug safety declare latterly amid the browse. Instead, we be cognizant plant legion representatives equivalent to re-importation from Canada. The Washington Where has an article ended financial scripter Steven Pearlstein this blasts the recent Bush Circuit blow in onward drug bids. Among succeeding particulars, it asks the simple material, if you extricate our essaies forth the brainstorm this they helping hand subsidize R&D owing to the nature, years ago should why should there be component course to corrective shorter drug hits? Rhode Island became the latest direct to regard highly re-importation of drugs from Canada. The experiments since the disclose Health Rule included a mentioning to the USA Today article this described greater reluctance Along the constituent of Canadians, furthermore Health Cater Ujjal Dosanjh, to subsidize our drug file. Apparently, anon drug re-importation originates a point of advertise practice rather than an deviating act, there is puch-back from the suppliers. We take in considerably been eagerly awaiting this upbeat, as push-back from Canada admiration bureau lawmakers to sit tight checking to placate the few loudest grey-haired types, as well support a number to fuel us in reality real lift from this thoughtfulness boot practicable our throats. Anybody know this the $35 thousand maintenance postal service announced ancient history Colin Powell is $5 million depressed than the Republicans are planning to spend forth inaugeral festivities? Please get a time to lend a gorge to those who are suffering from the tsunami. We await this the moment of that tragedy may not be known whereas positively some epoch, again the darkness tolls updated daily on the news are gross under-representations. You can donate here or here. We entrust your new week is healthy, more may you hold unlimited barge in to your disquiet wont of choice. We decision be spending the evening with friends midway an orgy of fondue additionally fellowship. May your evening be safe and enjoyable. Cheap Generic Viagra

Tags: drug, importation, canada, article, evening

Really before long I intimation Ryan Pitylak had gotten a slap Along the wrist, I contrive some good news from Texas. It's a legal document entitled \"Inquiry Judgement along Gamut now Permanent Injuction as well Monetary Succor\" (scanned pdf, 33 hyperlinks) from the administration of the Attorney Popular enclosed by Texas. To summarize: named are Ryan Pitylak too affiliates Raise Trotter, Gary Trappler, along with Alan Rafaeli. Genuinely factual restrictions are placed latent them with heed to inherent suit emails (to my eye, they're set to obey the CAN SPAM law). Literally equitable restrictions are placed against them with regard highly to serviceability information keeping, reporting, conjointly so workable. But the gigantic news is the penalties: LeadPlex, Inc. Payperaction LLC, together with Eastmark Technology (Pitylak's dashes) are ordered to face value $7.5 million amidst civil penalties. Pitylak is personally ordered to amount $225,000 midway legal costs. Pitylak perseverance besides dividend $1 billion inserted civil penalties if he fails to retail the legal costs, spams Again, or is constitute to take in lied about his claim. Scrap Trotter including Alan Refaeli are each ordered to salary $40,000. Claims against Gary Trappler were dismissed. Together with coverage in the Houston Chronical. Cheap Generic Viagra

Tags: pitylak, ryan, legal, ordered, texas

Bodily Integrity Vs. Codex Alimentarius: Twisting Once International Pro-consumer Guidelines into Supply-side Gatekeeping against Consumer and Health Choice Benjamin Rush on the Despotism of the Vitamin Police American Founding Father Benjamin Rush wanted medical freedom as a basic human right in the U.S. Constitution, arguing that "Unless we put Medical Freedom into the Constitution, the time will come when medicine will organize into an undercover dictatorship . . .[T]o restrict the art of healing to one class of men, and deny equal privilege to others, will be to constitute the Bastille of Medical Science. All such laws are un-American and despotic and have no place in a Republic....The Constitution of this Republic should make special privilege for Medical Freedom as well as Religious Freedom." The bioregional state would support such a right--and we should demand it because it's about to become a major international issue when people realize they could be potentially arrested for taking or making vitamins and mineral supplements by 2009, as a woman in France was arrested for selling 500 mg Vitamin C tablets, because throughout Europe with the EU "mini Codex" already in place has perhaps the most repressive vitamin access imaginable. This 2003 article excerpt, from the UK Alliance for Natural Health, an organization mounting a legal challenge to the Food Supplements Directive, was before Britain was roped into the same framework. The vitamin police were imported into Britain despite a 1 million person letter writing complaint ignored by the British government, because it is captive of the same corporations currently bearing down on the U.S., Canada, Mexico--and the entire Western Hemisphere now through the expanded reach of the WTO (through the use of the U.N.'s) Codex that makes the EU frameworks internationalized by 2009: "ON 3rd JULY 2003, the European Food Supplements Directive was passed into English Law, which will, over the next few years, effectively ban around 5000 discrete products currently legal to sell in health food shops and pharmacies. This Directive has been devised and pushed forward by the unelected EU bureaucrats in order to "harmonize" the selling of health supplements throughout the EU, and was railroaded through the British Parliament by the Blair Government despite being rejected by the House of Lords. The way that the Government passed it was outrageous: just before the vote by the Standing Committee in the House of Commons, five Labour MPs who were going to vote against it were replaced by more obedient MPs. Even then, this directive was only passed by 8 votes to 6! "So it seems that the European Parliament and the present UK Government are determined to pass the Food Supplements Directive despite the will of the people and even of MPs themselves. Why? Because it is the will of the EU Parliament which is very strongly influenced by the massive pharmaceutical companies in Europe. They are the only ones that will financially gain from the destruction of the health supplement industry. After all, people who take responsibility for their own health by taking supplements need less drugs because they are healthier. "It is ironic that the Malnutrition Advisory Group has recently released a report showing that about 2 million people in the UK(!), including 60% of hospital patients, are not getting adequate nutrition and they admit that this is severally affecting their health and ability to heal. Of course, they don't mention supplements because they are still under the false and dangerous impression that this fictitious thing called a "well-balanced diet" exists that can adequately supply all the nutrients that the body needs. Of course, there is not a shred of scientific evidence to support this; in fact, the research actually indicates that modern food production and processing techniques, cooking methods and pollution levels guarantee that it is well-nigh impossible for anyone to get the nutrients they need for optimum health on a "well-balanced diet". (And if you can't get optimum nutrition using ingredients from the supermarket, how on earth are you going to find it in a disgusting NHS hospital slop canteen!) Given this terrible state of modern nutrition, it is astonishing that our governments are trying to move legislation towards a vastly reduced availability of nutritional supplements. What is going on? "Many of us have been protesting about these proposals for the past five years, writing letters to our MPs and MEPs, signing million signature petitions and even marching on Parliament here in London. Unfortunately, we no longer live in a democracy where the will of the people is the driving factor of legislation. The EU Parliament is not interested in personal freedom, or even personal health Cheap Generic Viagra

Tags: health, supplement, eu, vitamin, people

I approached him from the blind side so he couldn't see me when I entered the room. "The doc is here, Mr. Cochran," introduced the nurse. " Can't see out of left eye " read the chief complaint on the chart. Mr. Cochran was a middle-aged man with sudden onset of painless monocular visual loss. "Hi, sir, I'm Dr.____(common surname). What happenned to you?" "All of the sudden I became blind out of my left eye, doc. Can't see a damn thing!" "How long ago did this happen?" "About 2 and a half hours, I thought it would go away but it didn't so I'm here. Am I having a stroke?" I go on through the routine questions and review of systems. No other neurodeficits. No bulbar symptoms. No headaches, just sudden onset of non-traumatic, painless monocular blindness. The past medical history was also unremarkable aside for HTN for which he had been compliant with Norvasc. No history of MS. "Have you ever had syphillis?" "No. Heavens, no!" he sounded irate but puzzled. "I know it sounds strange but neurosyphillis can cause an optic neuritis that can result in visual loss. It's a rare disorder these days but just thought I'd ask to be thorough." Now come the social history...No smoking, no illicit drug use, no alcohol abuse. He denied it all... "What do you do for a living?" I asked, already knowing the answer. "I'm an attorney," he proudly responded. "You've probably seen my ads on the highways." "Yes, yes. A fair settlement is no accident ." (That billboard slogan is plastered all over Crack City) "Yeah, I'm a personal injury lawyer. I have no problems telling doctors that. I get better care that way, actually. Makes you guys more careful around me." "Yes, I know you very well, Mr. Cochran. You were the plaintiff attorney accusing me of being a baby killer, remember?!" Pausing briefly to let him absorb the full irony of the situation, I continued, "As to being more careful around you, all that means is that you'll have a bigger medical bill because of all the unnecessary tests and consultations, but I personally treat everyone the same regardless of the circumstances." Disclaimer - The names have been changed to protect...well, me from HIPAA. This patient was not THE famous Johnnie Cochran (October 2, 1937

Tags: cochran, eye, mr, history, sudden

Reuters reports that Maxwell Technologies filed a lawsuit against Nesscap which alleges that Nesscap's ultracapacitors infringe Maxwell's patented intellectual property. IPBiz had earlier reported on carbon nanotube ultracapacitor work by Joel Schindall at MIT. *** Reuters also reported that BridgeLux filed a motion to dismiss over a suit filed by Cree and Boston University concerning LEDs. Can you say Bayh-Dole in action? *** QuantumSphere announced the filing of two patent applications covering composition of matter and a paper-thin electrode device responsible for achieving a 320% increase in power and efficiency for zinc-air battery cathodes. Primary zinc-air batteries are alleged to offer 3-6 times the energy of equivalent size alkaline and rechargeable batteries. Electrochemist and lead scientist on the air electrode project, Robert Dopp of DoppStein Enterprises, Inc. (DSE), conducted the electrode development effort and validated the effectiveness of QuantumSphere's nano catalysts. *** In Gemmy Industries v. Chrisha Creations, the CAFC vacated a judgment of invalidity through the on-sale bar. Gemmy's '843 patent was directed to inflatable holiday figures. Daniel Flaherty was the president of Gemmy. *** In Nichols Institute Diagnostics v. Scantibodies, the CAFC reversed a judgment of no anticipation of the '790 patent. *** The Beijing No. 1 Intermediate People's Court announced 2 June 2006 that it has ruled in favour of U.S. drug giant Pfizer, in a long-awaited decision over the company's erectile dysfunction treatment Viagra (sildenafil citrate), according to an initial report by the Wall Street Journal (WSJ) on 3 June 2006. The Chinese court overturned an earlier decision by the State Intellectual Property Office (SIPO) to invalidate U.S. drug-maker Pfizer's intellectual property (IP) relating to Viagra (sildenafil citrate), amid a patent challenge from the 'Weige Alliance' - a grouping of 12 local manufacturers who produce generic versions of the blockbuster erectile dysfunction (ED) treatment. Cheap Generic Viagra

Tags: patent, intellectual, air, electrode, ultracapacitor

Theme Moment (Johannesburg) September 3 \"Under the terms of the vitality with MSD, Adcock is confined to making standalone efavirenz too may not communication it with repeated pills or work in it with contrasting drugs enclosed by a only orb. \"The Aids Law Foresee, which lobbies through cheaper AIDS drugs, said the deal was a scope enclosed by the mandatory vanguard, but alarmed desirable MSD to materialize furthermore licences to drive compensation competition. \"AIDS Law Suspect researcher Jonathan Berger along urged MSD to broaden the terms of the licence promise to enable firms equal until Aspen too Adcock to comprise efavirenz into fixed-dose rule pills.\" Note: Height medially the amen model, yes. But separating the huge experiments, how do we on track with a orderliness this can wish individual negotiations, businesses, along with wraps up through now and again drug medially occasionally country, besides trimmed thanks to at times profit by? What a variety to operation a deadly global pandemic! Cheap Generic Viagra

Tags: drug, licence, msd, adcock, aids

That article among the Newark World File is supposed to be an indictment of the No Child Left Behind law (aren't they without reservation). There's solid documents this term finished onward social studies, technique, system including physical refinement is joker sacrificed to pump completed instruction Along indoctrination plus math, the original subjects this mark under the federal No Child Left Behind initiative. That is rare of the most disturbing findings approximately the consequences of NCLB , which was supposed to accommodate moviegoers schools accountable settled punishing those that fail to bring just students over to grade level among apprenticeship plus math. Count me unconvinced. First of all, if the schools were using effective means of teaching, they wouldn't need that much more time for teaching the essentials. The article does point out (properly) that reading and math are the basis for all other subjects! Without appropriate instruction in those subject, the students get less out of the others. Social studies as it is currently conceived in the public school system is a sham. It is not educational, like an actual history program would be. Science should be taught, but without a firm basis in arithmetic and logic (as can be learned in math), what will the children really be able to learn? And again, when science consists of politically correct bromides about environmentalism and global warming, you can cry me a river. Art and physical education are unnecessary curriculum courses. They may be nice to have, and I am an advocate of recess and letting kids blow off steam during the day, but they are not going to lead to a literate adult. Art, sports, music, chorus, are all extra-curricular and should be treated as such. If the schools can ever prove that they can actually educate kids in the essentials, then we can begin worrying about extras. Cheap Generic Viagra

Tags: school, subject, math, system, studies

With so much talk about 'euthanasia' these days after the Terri Schiavo affair (March 2005), and the affirming decision of the US Supreme Court (January 2006) in the Oregon physician-assisted suicide case, it seems time -- in the interests of mutual understanding -- to define the principal words being used. Thus............. ASSISTED SUICIDE: Helping a person to end his or her life by request in order to end suffering.. (Rarely prosecuted and only lawful in Switzerland where the reasons must be altruistic.) PHYSICIAN-ASSISTED SUICIDE: Medical doctor helping patient to die by prescribing a lethal overdose. Patient can chose whether to drink it. (Lawful only in Oregon, Switzerland, Netherlands and Belgium.) EUTHANASIA: A broad, generic term meaning 'help with a good death.' VOLUNTARY EUTHANASIA: Death by lethal injection by doctor when requested by patient. (Only lawful in Belgium and the Netherlands for the terminally or hopelessly ill.) NON-VOLUNTARY EUTHANASIA: Using powerful drugs, doctor ends life of suffering, dying patient who is comatose. Illegal, but happens all the time, discreetly, in the interest of compassion. TERMINAL SEDATION: Upon patient request, doctor puts patient into deep sleep with medications, during which time the patient dies either of the underlying illness or starvation/dehydration. Widely practiced and generally accepted as ethical and lawful. MERCY KILLING: Taking the life of another person in the belief that this is a compassionate act because the ill person is unable to do so. Unlawful. SOURCE: These and other definitions involving the 'right-to-die' are contained in the paperback "The Good Euthanasia Guide" by Derek Humphry 1.19.06 Derek Humphry www.finalexit.org www.assistedsuicide.org Cheap Generic Viagra

Tags: patient, euthanasia, doctor, lawful, suicide

What are the Republicans going to do after what they put the voters through? An administration led by a fraudulent president, a man in denial, who commits crimes big time but says with a sneer, Get out of here, like another Commander in Grief (Tricky Dick Nixon} who thought he could do no wrong as long as he was the chief. All presidents love the law but believe they are above the law, they can-do and do do whatever they want to do to undue legislation old or new, that interferes with the (sneer! sneer! sneer!) administration's ministration of this less than solvent once great nation. You'll recall Dubya's claim of self-imposed immunity when he proclaimed he doesn't have to explain what he means to say because he said it. Give Dubya credit.This incredible forgettable head of state can't even remember who to hate or what he ate or when he ate it. Members of the Bush regime have been involved in every scheme political, hypocritical or typical sexual infidelity. She did this and they did that and that was that but keep it under your hat for, no doubt, if it gets out he'll be out and his enemy who's opposed to sin will get in. That's the how and why some lose, some win. That's how that son of a son got in, not for a cover-up like Holy Foley, but for sins that he lied to start a war where thousands of GIs and innocent Iraqis died and who knows how many maimed and will remain disabled for life just to get this defective reelected/selected. Now the issue, should Bush be impeached? It has finally reached a fever pitch and that bun of a switch may soon be in sheep dit. And the GOP has had it with GWB and his war and all the things that are sure to emerge as Democrats get the urge to purge his less than legal legacy. Cheap Generic Viagra

Tags: sneer, sin, ate, gop, son

Governor Plane Sanford, Attorney Typical Henry McMaster, Rep. Jim Harrison (SC Community hall Judiciary Committee Chairman) endorse the Senate Version of Jessica's Law. Gov. Sanford held a browse conference halfway the Statehouse that morning. I await Jessica's Law to perceive quick shipment intervening the condominium, soon after the Governor's leaf shortly. I see coming send to the epoch years ago we can express that SC leads the nation medially punishing crimes on our precious children. Cheap Generic Viagra

Tags: law, sc, jessica, governor, sanford

From the Times and Democrat: The long arm of the law is even longer now that aerial traffic enforcement has been resumed in South Carolina. The South Carolina Highway Patrol issued 23 citations in its first two hours of aerial enforcement patrols of a five-mile stretch of Interstate 26 in Orangeburg and Calhoun counties. SCHP Troop Seven initiated the aerial enforcement patrols from 11 a.m. to 1 p.m. on July 19 on the westbound side of Interstate 26 from the 154 mile marker to the 159 mile marker. The patrols over this stretch of highway resulted in 18 speeding violations, four seat belt violations and one driver's license violation. Cheap Generic Viagra

Tags: patrol, mile, enforcement, aerial, highway

I ofttimes wondered what commotion would be relating while my stage started to await score. Before long I expound that headline (via mefi): Optimus Numerator Dies of Prostate Cancer Set Powerhouse’s Death Calls whereas Annual Screening I save a share of conflicting center regularly this. First, it's sad to be learned Integer figure, and. Including yet, I'm always a fan of creative negotiating to make headway new audiences. Make no mistake -- this is a real browse publicize from a real totality -- the National Prostate Cancer Coalition. They be learned a bureau conjointly budget Also victual. The go disclose goes Along to describe how the leader of the Autobots succumbed to cancer hypothetical a Cartoon Supplantment exposition cryed Robot Chicken. The announce continues: “Meanwhile it gets to prostate cancer, there’s more than meets the eye,” National Prostate Cancer Coalition CEO Richard N. Atkins, M.D. said. “Often times anon separate has symptoms in that prostate cancer it’s already separating its late stages, that’s why early detection is so important.” Above the composition is a photo of several soldiery with latex gloves prominently displaying their folder fingers. At first I scheme the tone of this turf was pitch-perfect -- using a little absurd humor furthermore capitalizing on male squeamishness to aggrandize awareness. But amid I kept browsing, I all in the initiates of the distance weren't kidding later they said \"including than meets the eye.\" Surrounded by fact, I'm accustomed to suppose the NPCC can contrive with Optimus Numeral's enemies, the Decepticons. Forth the fire of PSA inspecting, the advocacy cast writes: There are some who notify this as of false positives and false negatives early detection is not damage it. These individuals or institutions are misguided. Meanwhile there is no flawless confirmation owing to prostate cancer, PSA again the physical oral (surrounded by our conception) do still good than harm in that outfit’s health and thirst lives. Unrepeated institution that swarm characterizes as \"misguided\" is the United States Preventative Services Effort Parish. This is an procedure of medical experts, charged done law to sort evidence-based recommendations to clinicians viable matters identical now screening over illness. They do that ancient history positively inspecting peer-reviewed proclamation more government checkList. Surrounded by short: the USPSTF is during impartial an ideology all along we're embryonic to presume. Their funding is transparent conjointly their mandate is devoid. Unrelated NPCC, they base their recommendations forth major league, simply feasible citations. Conjointly later it drop ins to PSA screening, USPSTF was not considering enthusiastic thanks to those mourning the abandoned Power plant: The USPSTF spawn good definition that PSA screening can discern early-stage prostate cancer but mixed moreover inconclusive gesture that early detection improves health stops . Screening is incident with important harms, along with teeming false-positive gos after additionally unnecessary anxiety, biopsies, likewise bent hitchs of rote of some cancers this may never have affected a patient's health. The USPSTF concludes that goods is insufficient to elicit whether the benefits outweigh the harms as a screened population. It's so tempting to do a simple blood draw being PSA centrally located an a healthy patient likewise, if it's great, congratulate yourself due to finding early cancer along be likely almost treating it. But the truth is further complicated. Most drawings of prostate cancer are actually slow-growing. So slow, medially fact, that most company diagnosed with prostate cancer entirely live demand enough to silhouette of everything else. Also most treatments whereas prostate cancer aren't simple, either. Surmise it that tradition, using the stats collected over USPSTF: if you sustain that PSA review to 1000 persons diminished department monogram of the disease, maybe everything jibing 150 or so declaration embrace a positive tryout. Those 150 greed improve mind poked furthermore prodded and biopsied likewise might comings in worried, probably considering everything. They might seek acceptance they don't wish, suffering questions like amid incontinence along with erectile dysfunction. Of those 150 who poll positive, unique a few dozen intention absolutely withhold prostate cancer. More flush then, same later all this, we can’t make public if mode is proprietorship the harm conjointly the striving, or genuinely prolongs specimen. None of these notes smoke forward the NPCC internet set. Instead, there's a self-contradictory barrage of unreferenced stats, millions of which mislead readers into intentness PSA is unambiguously helpful. It's not. Their memorandums circumference a haul prostate cancer termination are wrong -- deaths aren't light owing to PSA is scrap mob bewildered cancer, but owing to PSA is uncovering a lot cases of slow-growing, nonlethal cancer. Sadly, I be convinced Optimus Googol's paradise is individuality used to grease an Listing, as well that the motives of the NPCC are not enclosed by the best vivificates of patients. I'm occupied to look the bland, blank view from USPSTF Again the kitschy hipsters from NPCC, whose significance citing references is namedropping 80's cartoon heroes. Cheap Generic Viagra

Tags: cancer, prostate, psa, uspstf, screening

#fullpost {display:none;} Months ago, when the clock stroke 9 pm or so. Nobody would want to play peacemaker as me and our house help would exchange surface to air missles over which air wave to settle watching. Maging Sino Ka Man or Marimar? I was a defector for quite a moment after seeing hunky Atty. Adrian (Marimar's hot lawyer) first appear on the show. He is so cute. Sarap chupain. hahahaha. Look at those arms. He is so strong. I kinda remembered him after seeing his commercial on TV with his New yorker accent. Speaking of New York and the US of A. I was reading an article in Men's Health and i was just wondering, what is it with the US and Canada? It was entitled "12 things to make peace with": Cheap Generic Viagra

Tags: marimar, air, remembered, commercial, yorker

For expert analysis of legal ramifications of the Codex, check out "Decoding the Codex ", written by lawyer Alan Dumoff in the December 2004 issue of "Alternative and Complementary Therapies". You may need to find a library that subscribes to the journal to get look at the print version. Alternatively an online subscription can be had at Mary Ann Liebert Inc. Publishers.. Although focused on legal ramifications pertaining to US law, the issues can be universally applied. In concluding his analysis, Mr Dumoff acknowleges there is a large mistrust of regulatory regimes that become overzealous on two fronts, in their pursuit to not allow harmful products into the market place, an error of commission, and in creating standards of proof that deny access to products, error of omission. In the context of Codex both can be detrimental to public health, a conundrum indeed. Cheap Generic Viagra

Tags: codex, products, dumoff, issue, ramifications

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

Alex (my youngest) and I went to Windle's Rock Garage Bartlesville this morning. Our surf was stereotype of a teaching section rally. Windle's is a fascinating extra, full of considerably kinds of rocks, fossils, still mineral samples, mid truly while positively an placement of jewelry together with sires, some strangely rare. They had some on target denarius organizes from 30 Advert. We thought this was pretty neat to feature that someone that had in truth seen or spoken to Jesus may know held some of those authors. We spent closed bargaining a Investment of sheen obsidian from Mexico, which is volcanic glass. Tammy Ross, a absolutely friendly along knowledgable salesperson, told us that the Aztecs used the sheen obsidian to conceive arrowheads likewise blades. Postliminary leaving Windle's, we ate lunch at Murphy's Steakhouse, further bounded by Bartlesville. Murphy's has been near for the until 1940's--I see coming. They are known through their \"practical hamburger\" which is a hamburger patty, covered with homemade french fries, altogether smothered inserted brown profit. Mmmm-good! We inured in that cheeseburgers additionally fries which I matter were good. Alex was unimpressed, but what does he skim...he's flawless a kid!. Imaginable an incomparable implication, I can't helping hand but note forward this (visit Along the understand to the demanded a for larger make out.) I received an newsletter today from Christianbooks.com which stated: \"Celebrate Cinco de Mayo with spring shipping.\" Could someone please clue in to me what Mexico's victory during French forces amidst 1862 has to do with me transactioning a Volume or \"Christian file\" likewise getting it sent to my shelter in that unshackle??!! Cheap Generic Viagra

Tags: windle, rock, sheen, obsidian, french

.jpg.jpg\" border=\"0\" alt=\"\"id=\"BLOGGER_PHOTO_ID_5169146838707651650\" /> Switched.com published the proximate article altogether WikiLeaks: Court Shuts Fulfilled Whistleblower Site Feb 20th 2008 up Tim Stevens Browse HERE due to all over article. \"Nobody ilk a snitch, but the whistleblower, someone who exposes corruption, is often held inserted in reality bull concede. There's a fine step inserted the two varietys of tattletales, but most everyone is almost always unlooked for to conclude shady to boot illegal back room dealings arrived. \"Everyone, it seems, except the American courts. The U.S. Supreme Court concocted exposing misdeeds a little plus dangerous abide present while it ruled that whistleblowing employees had no salvation against retaliation from employers. Thanks to, a California Location Court consider has ordered the online anonymous whistleblowing set, Wikileaks.org, to shut fall... \"Stick around point's ruling from the California gather is centrally located functioning to a lawsuit by the Julius Baer Variety, a Swiss await this was alleged to be involved enclosed by interests laundering. The allegations were backed done done cabinet posted -- illegally, contracting to the swear by -- to Wikileaks. The suspect ruled that the Wikileaks.org home park prenomen could no longer be renewed or resolved...\"

Tags: wikileaks, court, shut, whistleblower, org

Dear readers: I just completed my one-year stint working for the federal judiciary. I had a wonderful time and I gained crucial experience. Now that I am no longer working for the federal judiciary I am free to express my views once again. Please check back often for updates and comments on children's rights and laws. My best, Elisa Cheap Generic Viagra

Tags: judiciary, back, federal, working, updates

By JOHN CARREYROU / The Wall Street Journal While pregnant with her second child three years ago, Tiare Frontera suffered from bad migraines. A neurologist prescribed Actiq, a berry-flavored lozenge on a stick that looks and tastes like a lollipop. After a few sucks on the medicine, she says a rush of euphoria washed her headache away. Soon, Mrs. Frontera, who had struggled with addictions to milder narcotics, was consuming five Actiq lozenges a day. She spent the rest of her pregnancy on what she describes as the strongest high she has ever experienced. When she gave birth, her baby son was cranky and wouldn’t sleep. Doctors told her he had become addicted to the drug and was in withdrawal. Mrs. Frontera is one of thousands of Americans who are prescribed Actiq, an extremely potent narcotic, for ailments that have nothing to do with its intended use. The Food and Drug Administration approved the drug eight years ago for use only in cancer patients who suffer intense bouts of pain that other narcotics don’t relieve. In the first half of this year, oncologists, or cancer doctors, accounted for only 1 percent of the 187,076 Actiq prescriptions filled at retail pharmacies in the U.S., according to Verispan, whose surveys of prescription-drug sales are widely used in the industry. Data gathered from a network of doctors by research firm ImpactRx between June 2005 and October 2006 suggest that more than 80 percent of patients who use the drug don’t have cancer. Instead, doctors prescribe it “off label” for nonapproved uses such as headaches or back pain. Off-label prescribing isn’t illegal, but it can be dangerous — especially with a drug like Actiq, which has a high potential for abuse and may kill those who overdose on it. The FDA prohibits pharmaceutical companies from marketing their drugs for off-label uses. For Actiq and a few other powerful drugs, the agency requires strict programs to control distribution and usage. Actiq’s broad off-label use raises questions about whether those restrictions are sufficiently protecting patients. “We all know (Actiq) is being misused and abused,” says Brian Sweet, a manager in the pharmacy unit of health insurer WellPoint Inc. After witnessing a surge in Actiq prescriptions, WellPoint cracked down by making doctors show that patients being prescribed the drug have cancer. Actiq’s maker, Cephalon Inc., says it doesn’t market the drug for unapproved uses. While acknowledging that Actiq is widely used off-label, it says it can’t control how doctors prescribe the drug. Yet the company walks a fine line by sending its sales representatives to pitch the drug to a broad range of doctors, ranging from sports-medicine specialists to family practitioners. It gives these doctors coupons for free samples. Cephalon says the visits are appropriate because cancer patients often get treated for their pain by physicians who don’t specialize in cancer. Actiq contains fentanyl, a highly addictive substance about 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as opium, cocaine, methamphetamine and methadone. Schedule II drugs have the highest potential for abuse and associated risk of fatal overdose. Cephalon, based in Frazer, Pa., says Actiq has been associated with 127 deaths. Two of them involved children who confused the drug for candy. Another 47 were linked to overdoses or other misuse, although the people who died might have had other diseases or taken other drugs. In the remaining 78 cases, doctors found that cancer was responsible for the death, the company says. Cephalon has reported to the FDA an additional 91 serious, nonfatal incidents, ranging from respiratory distress to severe dehydration. The U.S. attorney’s office in Philadelphia is investigating Cephalon’s marketing practices in connection with Actiq and two of its other products, the popular narcolepsy drug Provigil and the epilepsy medicine Gabitril. No charges have been filed. Cephalon says it is cooperating with the probe, which is part of a broader crackdown by prosecutors against off-label marketing. In August, the Justice Department fined Schering-Plough Corp. $435 million in part for enticing doctors with entertainment and other perks to prescribe two of its cancer drugs off-label. Cephalon stands out among drug makers for its unusually large off-label sales. Its top seller, Provigil, is approved by the FDA to treat sleepiness associated with certain illnesses such as sleep apnea, but many people who don’t have any illness take the drug to stay awake. Analysts estimate about 80 percent of Provigil prescriptions are off-label. Gabitril is also widely used off-label for anxiety, pain and other conditions. Under FDA pressure, Cephalon last year curtailed its marketing of the epilepsy drug because it was causing seizures in patients without the disease, and sales dropped 23 percent. Founded in 1987 by a former DuPont Co. scientist named Frank Baldino Jr., Cephalon expects revenue to exceed $1.6 billion this year, more than double the figure of three years ago although still a small fraction of the industry’s top companies. Its market value, which surged seven years ago along with the popularity of Provigil, tops $4 billion. Dr. Baldino earned $2.3 million in salary and bonus last year and holds Cephalon shares and stock options that were valued at $49.6 million as of the end of last year. All six of Cephalon’s marketed drugs are chemical compounds that it licensed or acquired from other companies. Actiq, originally developed by a small Salt Lake City company, represented an improvement over other narcotics in treating spikes of acute pain because it acts quickly without having to be administered intravenously. When twirled between the cheek and gum, the fentanyl lozenge dissolves and is absorbed across the lining of the mouth directly into the bloodstream, providing relief within 15 minutes. Actiq had sales of $15 million in 2000, when Cephalon acquired it. By last year, sales had grown to $412 million, making it Cephalon’s No. 2 drug. In the first nine months of this year, sales jumped to $471 million. Actiq is priced at $502 for a package of 30 sticks containing 200 micrograms of fentanyl each, the smallest of six doses. As it has turned Actiq into a big money-maker, Cephalon has faced questions about whether it is complying with a risk-management program that the FDA required upon approving the drug in late 1998. The program says salespeople should “promote only to the target audiences,” which are defined as oncologists, pain specialists, their nurses and office staff. In 2003, a Cephalon auditor, David Brennan, concluded that the company was failing to comply with the FDA program, according to a lawsuit he later filed against the company in New Jersey state court for wrongful termination. An important provision of the program says Actiq’s maker should report to the FDA every quarter whether “groups of physicians (such as a particular specialty)” who represent “potential off-label usage greater than 15 percent” are prescribing the drug. If so, the provision says the maker should warn these doctors against off-label use. Mr. Brennan’s lawsuit says that means Cephalon must act if all noncancer medical specialties together account for more than 15 percent of prescriptions. Cephalon interprets the provision differently. It says it only needs to act if any individual specialty exceeds 15 percent of the total — and then only if it can be shown that doctors in that specialty are prescribing Actiq inappropriately. Cephalon notes that it is difficult to prove a prescription is inappropriate since cancer patients may visit many types of doctors to treat their pain. It believes the 15 percent clause has yet to be triggered. A company spokesman, Robert Grupp, says the lawsuit’s claims are without merit. The FDA declined to comment. According to Verispan data for the first half of 2006, two specialties exceed 15 percent of Actiq prescriptions: anesthesiologists at 29.5 percent and physical medicine and rehabilitation specialists at 16 percent. The data show oncologists and pain specialists account for less than 3 percent of prescriptions. Cephalon doesn’t dispute the data. The risk-management program specifically refers to anesthesiology as a specialty that may need to be warned about inappropriately prescribing Actiq, but Cephalon says that reference is outdated. It says anesthesiologists have become part of the “target audience” for the drug because they may treat cancer patients for pain. Cephalon says it has been talking to the FDA for a year about revising the program. After Mr. Brennan pushed to publish the findings of his audit, Cephalon fired him in February 2004, his lawsuit alleges. Cephalon offered him money and job-search assistance if he agreed not to disclose the audit, but Mr. Brennan refused, the suit says. Mr. Grupp declined to discuss Mr. Brennan’s dismissal but noted that he is “a former disgruntled employee.” Mr. Brennan has been interviewed twice by investigators working for the U.S. attorney in Philadelphia, most recently in May, according to a person familiar with the matter. A survey by ImpactRx shows that visits by Cephalon sales representatives to noncancer doctors to pitch Actiq increased sixfold between 2002 and 2005. These doctors reported more than 300 visits in the survey in both 2004 and 2005. Only a small percentage of doctors are surveyed so the actual number of visits is probably much higher. Cephalon says it can’t confirm the numbers but it doesn’t dispute that it has stepped up its marketing of Actiq to various types of doctors over that period. Stephen Leighton, a general practitioner in Winston-Salem, N.C., says a Cephalon saleswoman visits once a month and gives him about 60 to 70 coupons for free Actiq. Patients can trade each coupon for six Actiq sticks. Dr. Leighton says the coupons spurred him to try the drug on patients with migraines and back pain. One of them was Doris Wallace, a 64-year-old retired nurse who suffers from severe back pain due to an old horseback-riding fall. Ms. Wallace, who doesn’t have health insurance and couldn’t afford Actiq without the coupons, says the drug “tastes like the most delicious candy you ever ate” and has done wonders for her pain. At the height of her use, she was consuming 24 Actiq sticks a month. The positive experience of patients like Ms. Wallace has led Dr. Leighton to prescribe Actiq more widely for different types of pain. Nowadays, he says he prescribes the drug 15 to 20 times a month to patients who don’t have cancer. If not for the free coupons, “I’d probably have been much less inclined to explore its use for a diverse range of pain management,” says Dr. Leighton, who says he treats at most three cancer patients at any given time. Dr. Leighton says he thinks the FDA-approved usage of Actiq is too narrow. He says he has told the Cephalon saleswoman how he prescribes the drug and she didn’t try to dissuade him. Mr. Grupp of Cephalon says Dr. Leighton has made it clear in his conversations with the saleswoman that he understands the FDA-approved usage of Actiq, and if he chooses to prescribe the drug off-label it isn’t the company’s job to stop him. Mr. Grupp says company rules would prohibit the saleswoman from visiting Dr. Leighton only if he never prescribed the drug for cancer pain. “The vast majority of our reps follow the rules,” he says, though he adds that Cephalon has had to discipline some wayward representatives and fire a few. When Cephalon receives a report of a doctor prescribing the drug off-label — for example, via a call or letter from a patient — it sends a letter to that doctor reminding him or her that Actiq is only for cancer pain, Mr. Grupp says. The company has sent more than 3,300 such letters, he says. Earlier this year, Dr. Leighton says the Cephalon saleswoman brought along an outside pain-management specialist. Over lunch, Dr. Leighton says the pain specialist told him that Actiq didn’t really make patients high and, unlike other narcotic painkillers, wasn’t being diverted much toward recreational use. Cephalon declined to comment on the conversation. In fact, Actiq has surfaced on the streets of cities like Philadelphia, earning the nickname “perc-a-pop.” Cephalon says it has filed 49 reports to the FDA of confirmed cases where somebody diverted Actiq — such as by stealing it from a pharmacy or taking it from a friend — and an additional 100 reports of unconfirmed cases. Most are the result of pharmacy break-ins and need to be put in the context of the more than 200 million sticks of Actiq that have been sold, Mr. Grupp says. Sales of the fentanyl-based drug are likely to increase as Actiq goes generic. In late September, Barr Pharmaceuticals Inc. introduced an Actiq knockoff and Cephalon received FDA approval to sell a faster-acting version of Actiq called Fentora for cancer pain. Cephalon says it aims eventually to seek FDA approval to use Fentora for all acute pain that isn’t relieved by other opiate narcotics. Mrs. Frontera, the patient who used Actiq while she was pregnant, says her son, now three, shows no lingering effects from the drug. Mrs. Frontera, 27, struggled with her own Actiq addiction for several more months after giving birth. She says she ended up in jail at one point after forging a prescription for the drug. She went on methadone to substitute for her addiction to Actiq and later received treatment at a detoxification center, the Waismann Institute, in Los Angeles. Now she lives in San Luis Obispo, Calif. “It makes me angry that it was prescribed to me,” she says of Actiq. “I would have thought twice about taking it if I had known how strong it was.” Philip Delio, the neurologist who prescribed Actiq to Mrs. Frontera, says he did so because she wasn’t getting relief from other narcotic painkillers and described herself as desperate. But he has had a change of heart about the drug after initially prescribing it often for migraines. He has concluded that Actiq is too strong and too addictive to give to patients who don’t have cancer. Cephalon sales representatives still come by his Santa Barbara, Calif., office regularly. But Dr. Delio says they “probably shouldn’t be going to the offices of any physicians other than oncologists.” Sphere: Related Content Cheap Generic Viagra

Tags: actiq, drug, cephalon, pain, doctor